Article
Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Pharmacogenomics - 1 Jun 2011
Cui Lian-Hua, Yu Zhuang, Zhang Ting-Ting, Shin Min-Ho, Kim Hee-Nam, Choi Jin-Su
Abstract excerpt
AIMS: Genetic factors may contribute to individual differences in cancer susceptibility, drug efficacy and toxicity. This study was designed to investigate the effects of the polymorphisms of methylenetetrahydrofolate reductase 677 C→T (MTHFR 677 C→T), thymidylate synthase (TYMS 3R→2R),and methionine synthase 2756 A→G (MTR 2756 A→G) on the risk of lung cancer and response to platinum-based chemotherapy in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
